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Background: despite knowledge about HPV may be an important determinant for vaccine acceptance 
and uptake, only few studies have assessed HPV-related knowledge in young females. 
The aim of this study was to assess the reliability and validity of the questionnaire, in Italian women 
≥18 years old, as a tool to examine knowledge, attitudes and behaviors towards screening and 
vaccination against HPV and reliable source of information.
MeTHods: The questionnaire was administered to 30 girls in anonymous, voluntary and self 
-administered form with close-ended type of questions, except for the socio-demographic 
characteristics. It was composed in 3 sections for a total of 69 items. Participation in the study 
was entirely voluntary and anonymous. descriptive analyses were performed using frequencies, 
percentages, and frequency table for categorical variables. reliability analysis was tested and 
content validity was evaluated using cronbach's alpha to check internal consistency and avoid 
misinterpretation of the results. The study was conducted in 4 Italian cities: Ferrara, rome, cassino 
and Palermo, to represent the different Italian geographical areas and knowledge, attitudes and 
behaviors towards screening and vaccination against HPV and reliable source of information. data 
were collected in october 2010. statistical analysis was performed with the statistical software for 
Windows sPss, version 19.0. 
resulTs: The highest value of cronbach’s alpha resulted on 24 items (alpha= 0,774); the addition 
of other items, one at a time, decreased the value. cronbach’s alpha on all the 3 sections together 
resulted in a value of 0, 059. Young women generally knew that HPV can cause cervical cancer 
(93.3%) and genital warts (16.7%) and 76.7% of them recognized Pap-test as a screening tool. The 
main sources of information about HPV vaccination are represented by magazines / books (33.3%), TV 
(26.7%), and gynecologists (23.3%).
conclusIons: This pilot study demonstrated that a short version of the questionnaire has very good 
reliability properties in the study and this needs to be taken into account for future studies.
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Background  
Human papillomaviruses (HPVs) are 
double-stranded DNA viruses belonging to 
the papillomaviridae family, with tropism for 
squamous epithelium. Over 120 types of HPV 
have been identified and approximately one 
third of these infect the squamous epithelia 
of the genital tract [1]; the viruses are the 
causative agents of over 99% of cervical 
cancers, which is the second largest cause of 
cancer deaths in women [2].
The types 16 and 18 causes up to 70% of 
cervical cancers worldwide and the majority of 
HPV-related precancerous lesions in other parts 
of the body, while HPV types 6 and 11 have been 
implicated in 90% of cases of genital warts [3].
The prevalence of HPV infection in women, 
according to data from 59 countries, ranges 
from 2% to 44% depending on the geographic 
region, the population sampled and the method 
of analysis [4].
In Italy, studies in women aged between 17 
and 70 years, during routine gynecological tests 
or screening programs, showed a prevalence 
for any type of HPV between 7 and 16%; if 
women have abnormal cytology the prevalence 
increases to 35-54%, and 96% in case of severe 
dysplasia or beyond [5]. Genital HPV infection 
is relatively high with a prevalence of 24.1% 
among sexually active Italian women aged less 
than 25 years [6].
The HPV vaccine may have a substantial 
role on public health worldwide [7] and may 
reduce significantly the incidence of cervical 
cancer protecting against infections [8].
The Pap-test is an effective preventive 
measure in reducing cervical cancer incidence 
and mortality, it is recommended by the EU 
commission guidelines, which also recommend 
implementing organized screening programs, 
because they assure quality control, timeliness 
of testing, and equity of access to care [9]. In 
accordance with international guidelines, in 
Italy the Pap-test is recommended every three 
years for women between 25 and 64 years. 
Screening programs adherence has increased 
over the years, however, the invitation rate 
remains insufficient (38%) compared to 
the levels recommended by the European 
Guidelines and the National Commission 
cancer (85% of target). Moreover, there are 
important geographical variations, with a 
decreasing trend from North to South of Italy 
(46% in the North, 36% in Central, 24% in 
the South) [10]. It should be noted that many 
women perform a Pap-test, even without 
participating in organized screening programs. 
A study shows that 78% of women, that ought 
to be involved in screening programs, have 
had a Pap-test as a preventive measure and 
70% of them within the last three years [11].
Despite knowledge about HPV may be an 
important determinant for vaccine acceptance 
and uptake [12-13], only few studies have 
assessed HPV-related knowledge in young 
female [14-16].
Research is needed to fill the gaps in 
knowledge and perception about the HPV 
vaccination, it is not clear if young women 
understand the purpose of the Pap test, 
regardless of recent advancements and national 
attention over cervical cancer prevention.
The aim of this pilot study is to evaluate 
the reliability and validity of the questionnaire 
in young women (≥18 years) as a tool to 
assess knowledge, attitudes and behaviors 
towards primary (anti-HPV vaccination) and 
secondary (Pap-test screening) prevention of 
cervical cancer.
MeTHods  
study population 
We administered an ad hoc questionnaire, 
as a tool for the pilot study, among an 
Italian sample of 30 young women ≥18 
years. Questionnaires were anonymous and 
self-administered with close-ended type of 
questions, except for the socio-demographic 
characteristics (father/mother employment, 
nationality, religion, residence). Participation 
in the study was completely voluntary.
The respondents were selected with 
opportunistic sampling in waiting rooms of 
the Local Health Unit, before the vaccination, 
and in university classrooms of four Italian 
cities enrolled in the study. The survey 
included 30 young women in order to verify 
the validity and reliability of the questionnaire. 
The survey was carried out in 4 Italian 
cities -Ferrara, Rome, Cassino, Palermo- in 
a multicenter study funded by the Ministry 
of Research (Progetto di Ricerca di Interesse 
Nazionale, PRIN 2008). The regions of the 
participating Universities where selected to 
e 8 9 1 3 - 2
OR IG INA L  AR T I C L ES
Epidemiology Biostatistics and Public Health - 2014, Volume 11, Number 2
VALIdATION Of A quESTIONNAIRE fOR yOuNG wOmEN TO ASSESS kNOwLEdGE, 
ATTITudES ANd BEHAVIORS TOwARdS CERVICAL BSCREENING ANd VACCINATION AGAINST HPV IN ITALy
be as representative as possible of the 
different Italian geographical areas relatively 
to knowledge, attitudes and behaviors 
towards screening and vaccination against 
HPV and reliable source of information. Data 
were collected in October 2010. 
The survey has been approved by the local 
ethical committee. 
Questionnaire
The full version of the questionnaire 
comprehends three sections and includes 69 items. 
The first section on anti-HPV vaccine deals 
with knowledge about diseases related to HPV 
infection, vaccination as a measure of primary 
prevention, information sources and methods 
of contraception.
The second section investigates knowledge 
and attitudes towards the Pap-test and the 
gynecologist-patient relationship.
The third and final section includes socio-
demographic data (age, educational level, 
current occupation, father’s/mother’s profession, 
nationality, religion and region of residence). 
The questions were all closed-ended 
except for socio-demographic characteristics 
(father’s/ mother’s profession, nationality, 
religion and residence). Table 1 illustrates the 
items of the questionnaire.
statistical analysis
Data entered into a database using the 
program DB IV were processed with the 
statistical software SPSS 19.0 for Windows. 
Descriptive analyses were performed using 
frequencies, percentages, and frequency table 
for categorical variables (Table 2). 
Cronbach’s alpha was used as a measure 
of the internal consistency that refers to the 
degree of correlation between the items, 
belonging to each of the 3 sections of the 
questionnaire and forming a scale.  In each 
domain of the questionnaire, the items should 
be correlated moderately with each other but 
should contribute independently to the overall 
score in that domain. 
When the Cronbach’s alpha is 1, it means 
that questions are measuring an almost identical 
construct, resulting redundancy. Generally, an 
alpha value of 0.7 is considered acceptable [17]. 
In addition, a reliability analysis was 
performed to examine whether any item was 
not consistent with the rest of the scale, 
and thus could be discarded. The item-total 
correlation and the variability of the alpha 
between items in each section, adding and 
eliminating items of each section one at a time, 
was performed.
resulTs
Validation of the questionnaire
The highest value of Cronbach’s alpha 
resulted on 24 items (alpha= 0,774) (Table 
3a). The addition of other items, one at a 
time, reduced the alpha value. Cronbach’s 
alpha resulted in a value of 0,713 on 41 items 
(Cronbach’s alpha of 0,7 is the minimum 
value to be considered acceptable). When 
other items were added, for a total of 
69 items, Cronbach’s alpha decreased to 
0,059, meaning that the full version of the 
questionnaire has an unsatisfactory internal 
validity.
Reliability analysis and item-total 
correlation and variability of Cronbach’s alpha, 
if one item was deleted are shown in Table 3.
sociodemographic characteristics of the sample
The sample consisted of 30 young women 
(≥ 18 years). About 50% resides in Southern 
Italy and 100% of the sample is Italian; also, 
70% declared to be catholic.
Fathers’ professions are: civil servant (43.6%), 
self-employed (20%), retired / unemployed 
(16.7%) and health professionals (16.7%).
Mothers of young vaccinated women 
are public employees (36.7%), self-employed 
(13.3%), housewives / unemployed (30%) and 
health professionals (20%) (Table 2).
knowledge
Concerning knowledge about prevention 
of cervical cancer, 76.7% of young women 
recognize Pap-test as a screening tool; 43.3% 
of the sample believes that only females 
should be vaccinated. On the other hand, 
both genders should be vaccinated according 
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table 1
HPV Questionnaire administered to 30 girls
Questions
HPV Vaccination ansWers
D1) Which diseases are related to papilloma virus?   
D1a Cervical cancer                    
D1c Genital warts                         
D1e Oral cancer                            
D1g Recurrent cystitis                 
D1i I don’t know                           
(specify)………….
D1b Bladder cancer
D1d Irritable bowel
D1f Esophageal cancer
D1h Anal cancer
D1l Something else
D2) Who informed you of the HPV vaccination?
D2a General practitioner            
D2c Friends                                     
D2e TV                                            
D2g Magazines                                
(specify)………..
D2b Gynecologist
D2d Radio
D2f Web
D2h Something else
D3) Who should provide the vaccine against HPV?
D3a Payed by the society        
D3b Partially payed by the society                                     
D3c At partial load of those who want to vaccinate
D3d I don’t know    
D3e Something else (to specify)…………………………………
D4) In case you want to vaccinate against HIV, how 
would you behave toward screening (pap test) for 
cervical cancer? 
D4a I won’t get a pap smear after vaccination
D4b However, I’ll get a pap smear
D4c I don’t know
D4d Something else (to specify)…………………………………
D5) When should someone get vaccinated against 
HPV?
D5a Before the first sexual intercourse 
D5b If you think you may have occasional partners
D5c If you have had more partners                                    
D5d After the first intercourse                                           
D5e Anytime                              
D5f Something else (specify)…………………………………
D6) At what age should someone undergo HPV 
vaccination?
D6a 11-13 years                              
D6c 18-21 years                                                    
D6g All ages   
D6f  Something else 
(specify)…………………………………    
D6b 14-17 years
D6d 22-26 years
D7) Who should be vaccinated? D7a Male                                         D7c Male and Female                            
D7b Female
if you’Ve already Had sexual intercourse ansWer tHe next four Questions
D8) How often do you have sexual intercourse?
D8a Once a week                              
D8c More than two times per 
week
D8e Less than once per month    
D8b Twice a week
D8d Once / twice a month
D8f Never (go to question 24)
D9) How many partners did you have in the last 3 
years?
D9a 1                                                
D9c 3 or more   
D9b 2
D10) What contraceptive methods do you use?
D10a None                                     
D10c Billings method                     
D10e Coitus interruptus                  
D10g Condom                                 
D10b Contraceptive pill
D10d Spiral
D10f Basal temperature
D10h Diaphragm
D11) In which circumstances do you use condom? D11a Always                                   D11c In occasional intercourses
D11b Never
PaP-test section
D12) Do you know Papanicolau test (pap test)? □ Yes     □ No
D13) Have you ever done a pap test? □ Yes     □ No
D14) During pap test, are you satisfied with the 
communicative aspects with your gynecologist?
□ Yes     □ No
D15) During pap test, did your gynecologist 
tell you about the possible diseases related to 
infection with human papilloma virus?
□ Yes     □ No
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to 53.3% of over-18s.
According to young women, HPV can cause 
cervical cancer (93.3%), genital warts (16.7%), 
cancer of the oral cavity (10%) and anal cancer, 
esophageal cancer and recurrent cystitis (3.3%). 
Up to 6.7% didn’t know what HPV causes. 
The main sources of information about 
HPV vaccination for the respondents are 
represented by magazines / books (33.3%), 
TV (26.7%), gynecologist (23.3%) and general 
practitioner (23.3%).
attitudes
The HPV vaccine should be offered free 
or partially payed by the society for 83.3% and 
13.3% respectively. Regarding sexual intercourse, 
table 1 (continued)
HPV Questionnaire administered to 30 girls
Questions
HPV Vaccination ansWers
socio-demograPHic data
D16) Age  …………………
D17) Educational qualification D17a Elementary school                         D17c Senior high school                         
D17b Junior high school
D17e Degree
D18) Current occupation
D18a Student                              
D18b Working (please specify type of employment) 
D19c Looking for work
D19) Father’s profession ……………………………..
D20) Mother’s profession ……………………………...
D21) Nationality ………………………………
D22) Religion ………………………………..
D23) Residence ……………………………….
The questions about “Father’s and Mother’s profession”, “Nationality”, “Religion” and “Residence” were all open type.
table 2
socio-demograPHic cHaracteristics of tHe samPle
socio-demograPHic cHaracteristics of tHe samPle n (%)
total 30 (100)
residence
North 15 (50)
South 15 (50)
nationality
Italian 30 (100)
Foreign 0 (0)
religion
Catholic 21 (70)
Atheist 9 (30)
Other 0 (0)
fatHer’s Profession
Health care worker 5 (16.7)
Public employee 14 (46.6)
Self-employed 6 (20)
Retired / Unemployed 5 (16.7)
motHer’s Profession
Health care worker 6 (20)
Public employed 11 (36.7)
Self-employed 4 (13.3)
Housewife / Unemployed 9 (30)
The questions about “Father’s profession” and “Mother’s profession” “Nationality”, “Religion” and “Residence” were 
open type. 
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items
scale mean if 
item deleted
scale 
Variance if 
item deleted
corrected 
item-total 
correlation
cronbacH’s 
alPHa if item 
deleted
d1a cerVical cancer 42,50 38,571 ,163 ,041
d1b bladder cancer 43,38 39,411 ,000 ,059
d1c genital Warts 43,25 39,929 -,144 ,074
d1d irritable boWel 43,38 39,411 ,000 ,059
d1e oral cancer                            43,38 39,411 ,000 ,059
d1f esoPHageal cancer 43,38 39,411 ,000 ,059
d1g recurrent cystitis 43,38 39,411 ,000 ,059
d1H anal cancer 43,38 39,411 ,000 ,059
d1i i don’t knoW 43,25 40,500 -,270 ,088
d1l sometHing else 43,38 39,411 ,000 ,059
d2a general Practitioner 43,13 36,982 ,393 ,002
d2b gynecologist 43,00 35,143 ,652 -,050(a)
d2c friends  43,25 39,929 -,144 ,074
d2d radio 43,38 39,411 ,000 ,059
d2e tV 43,00 40,000 -,131 ,080
d2f Web 43,38 39,411 ,000 ,059
d2g magazines 43,00 41,143 -,301 ,106
d2H sometHing else 43,38 39,411 ,000 ,059
d3a free Payed by tHe society        42,50 38,000 ,295 ,027
d3b Partially Payed by tHe society 43,25 41,071 -,394 ,101
d3c at Partial load of tHose WHo 
Want to Vaccinate 43,38 39,411 ,000 ,059
d3d i don’t knoW    43,38 39,411 ,000 ,059
d3e sometHing else 43,38 39,411 ,000 ,059
d4a i don’t make more PaP smear 
after Vaccination 43,38 39,411 ,000 ,059
d4b HoWeVer, i make PaP smear 42,38 39,411 ,000 ,059
d4c i don’t knoW 43,38 39,411 ,000 ,059
d4d sometHing else 43,38 39,411 ,000 ,059
d5a before tHe first sexual 
intercourse 42,63 38,554 ,112 ,043
d5b if you tHink you may HaVe 
occasional Partners 43,25 40,500 -,270 ,088
d5c if you HaVe Had more Partners                  43,38 39,411 ,000 ,059
d5d after tHe first intercourse                      43,25 40,500 -,270 ,088
d5e anyWay                              43,13 40,696 -,254 ,094
d5f sometHing else 43,38 39,411 ,000 ,059
d6a 11-13 years 42,75 42,786 -,538 ,141
d6b 14-17 years 43,13 40,125 -,158 ,081
d6c 18-21 years 43,25 39,643 -,080 ,068
d6d 22-26 years 43,38 39,411 ,000 ,059
d6f  sometHing else 43,38 39,411 ,000 ,059
table 3
item-total statistics - item-total correlation and Variability of cronbracH’s alPHa, 
if one item Was deleted 
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the vaccine should be given before the first 
sexual experience (73.3%), anytime (26.7%) and 
in case of multiple partners (3.3%). The 11-13 
years old, the 14-17 years old and people of all 
ages should be vaccinated according to 53.3%, 
26.7% and 23.3% of the sample, respectively. 
Among those who carried out a Pap test, 
72.7% affirm that they received satisfying 
information from their gynecologist; 100% of 
the sample declares that they will request a 
Pap-test after HPV vaccination. 
Behaviour
All the respondents are sexually active. In 
particular, 39.1% have sexual intercourse twice a 
week, 26.1% once a week. Most of them declare 
only one partner (52.2%) and 8.7% report three 
or more partners. The responders use condoms 
(52.2%), the pill (34.8%) and coitus interruptus 
(13%) as a contraceptive method. The condom is 
always used by 57.1%, only occasionally by 28.6% 
and never by 14.32% of the young women.
Up to 41.4% of the sample has done 
a Pap-test and 45.5% of them declare that 
their gynaecologist informed them about the 
possible diseases caused by HPV.
items
scale mean if 
item deleted
scale 
Variance if 
item deleted
corrected 
item-total 
correlation
cronbacH’s 
alPHa if item 
deleted
d6g all ages   43,13 36,411 ,499 -,014(a)
d7a male 43,38 39,411 ,000 ,059
d7b female 42,88 40,982 -,271 ,103
d7c male and female 42,88 38,411 ,108 ,042
d8a once a Week 43,13 40,696 -,254 ,094
d8b tWice a Week 43,13 40,411 -,206 ,088
d8c more tHan tWo times Per Week 43,00 36,857 ,364 -017(a)
d8d once / tWice a montH 43,25 40,500 -,270 ,088
d8e less tHan once Per montH 43,38 39,411 ,000 ,059
d8f neVer 43,38 39,411 ,000 ,059
d9a 1 43,00 42,000 -,426 ,124
d9b 2 43,00 36,857 ,364 -017(a)
d9c 3 or more   43,13 40,125 -,158 ,081
d10a none 43,25 39,929 -,144 ,074
d14 during PaP test, are you satisfied 
WitH tHe communicatiVe asPects WitH 
your gynecologist?
42,63 37,125 ,367 ,006
d15 during PaP test, did your 
gynecologist tell you about tHe 
Possible diseases related to infection 
WitH Human PaPilloma Virus?
42,75 36,214 ,470 -,018
d16 age 19,75 3,071 ,348 -1,440(a)
d17 educational Qualification 40,38 39,411 ,000 ,059
d18 current occuPation 42,25 35,357 ,934 -,047(a)
a  The value is negative due to a negative average covariance among items. 
*The number corresponds to the items shown in Table 1.
table 3 (continued)
item-total statistics - item-total correlation and Variability of cronbracH’s alPHa, 
if one item Was deleted 
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dIscussIon
Cancer is the leading cause of death 
worldwide and, specifically, cervical cancer is 
the second most common and the third most 
deadly gynaecological neoplasia worldwide. It 
is estimated that 80-90% of women will have 
this sexually transmitted infection at some 
point in their life, though only 3-4% of them 
will develop cervical cancer [18-23].
Considering that at present there is no 
cure for cancer, the best strategy to combat 
oncological diseases is through early detection 
and prevention. The methods currently 
available are vaccines to target specific viruses 
(primary prevention), in combination with 
screening (secondary prevention). Modifiable 
lifestyle-related risk factors are also important 
in cancer prevention. Vaccination has been 
proven to be highly effective against targeted 
diseases leading to the development of cancer, 
particularly if the vaccination is given in 
the early years of life. The need for regular 
screening should not be neglected and should 
be followed to detect unusual changes or 
abnormalities in the body. 
It is becoming more and more important 
to raise awareness about cervical cancer. 
According to our study, HPV is recognized by 
young women mostly as the cause of cervical 
cancer (93.3%) and genital warts (16.7%). 
Recent studies have shown different degrees 
of knowledge about HPV-related diseases and 
few data are available regarding the awareness 
of cervical cancer among Italian women, 
especially among medium -high school and 
university students. Results of different studies 
suggest that knowledge about cervical cancer 
among these women is insufficient [34-36]. 
There is need for accurate data on current 
knowledge of women about cervical cancer in 
order to develop effective programs and increase 
public awareness, and to organize prevention 
campaigns aimed at encouraging cytological 
examination or HPV vaccination. It seems that 
awareness-raising campaigns have a considerable 
impact on women’s knowledge about cytological 
examination as a screening tool.
This study underlines that vaccinated 
young women have general knowledge about 
secondary prevention of cervical cancer and it 
is interesting to note that they have sufficient 
knowledge about Pap-test as a screening tool: 
76.7% of young women in the present study 
recognized Pap-test as a screening tool for the 
prevention of cervical cancer.
As for the primary prevention of HPV, 
the majority of participants believed that only 
women should be vaccinated. This could be 
due to the fact that in Italy, the HPV vaccine 
is offered free to all 12 years old female 
adolescents, with a possible extension to other 
age groups based on regional criteria, but the 
cost of the HPV vaccine is often not covered by 
public funds in other age groups [37].
According to a study carried out by Censis 
Association, only a part of female population, 
those directly involved in the free vaccination 
program for adolescents, is properly informed; 
but, the decrement of vaccinated girls who have 
access to free vaccination shows that there is loss 
of attention to this issue [38]. Infact, the 1997 birth 
cohort was the first cohort invited to be active 
in most Italian regions in 2008. The purpose 
of the immunization program in Italy, defined 
by the Entente State-Regions, is to achieve 95% 
coverage with three doses of vaccine within 5 
years after the vaccination program: girls born in 
2001 will be invited for vaccination in 2012, and 
the vaccination coverage will be evaluated on 31 
December 2013 [39].
As for many other countries, vaccination 
programs against HPV have been established 
for women and men that have not yet been 
included in programs funded at national level 
[40-41]. Nevertheless, in our study, 43.3% of 
the sample believes that only females should 
be vaccinated and, on the other hand, both 
genders should be vaccinated according to 
53.3% of over-18s.
The survey conducted by Censis about 
HPV knowledge and attitude to vaccination, 
involved 3,500 women aged 18 to 55 years 
and showed a positive slope to prevention 
and vaccination against HPV, but the access to 
information is essential as well as the guide of 
a health care worker in the choice. 
According to the PreGio project (that 
involved 2289 women aged 18–26 years), 
in order to minimize cervical cancer risk by 
improving women’s adherence to preventive 
strategies, appropriate and adequate information 
dissemination, and guidance from health 
professionals appear to be crucial elements [42].
The results of the present study indicate that 
physicians play a marginal role considering that 
young vaccinated women prefer to inquire about 
HPV vaccination mainly through media such as 
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magazines and television, and the gynecologist 
is the third largest source of information; the last 
source are other health professionals, such as 
general practitioners, pediatricians and operators 
of Local Health Units (LHU).
Vaccine promoters may need to find more 
effective ways to encourage vaccination uptake 
in populations at high risk for contracting 
HPV [43]. That is the reason why even care 
providers must be involved; gynecologists 
and pediatricians should play their role as 
expert guides [38]. Clinicians and educators 
can play an important role in this regard, both 
in educational settings and in the community. 
In order to avoid misunderstandings, health 
care professionals in youth clinics and schools 
need to approach young women and clarify 
the relation between cervical cancer, HPV 
and sexual transmission [44]. More than ever, 
clinicians need regularly updated reviews, 
given the continuously increasing amount of 
new information regarding innovative cervical 
cancer prevention methods [45].
Although HPV vaccine has the potential to 
reduce the prevalence of cervical cancer, it is 
important to ensure that vaccination does not 
have detrimental effects on cervical screening 
and other health behaviours [46]. Fortunately, 
the belief that HPV vaccination may encourage 
sexual behaviour was not a prominent concern 
among the participants in this survey, which is 
consistent with the findings of other studies [47].
The results of a survey conducted in 
Italy by O.N.Da (Osservatorio nazionale sulla 
salute della donna - National Observatory 
on Women’s Health) reported a 65% of 
immunization coverage, ranking after the 
United Kingdom (81%) and Portugal (80%): 
a good result in comparison to countries like 
France, Luxembourg and Norway, with  a 
coverage between 17% and 30%. However, 
the goal of 95% of coverage is still far because 
of lack of information and miscommunication 
on the importance of primary and secondary 
prevention [48]. 
Considering that perceived benefits of HPV 
vaccination also contributed significantly to 
the intention to be vaccinated, the acquisition 
of more knowledge about vaccine safety and 
efficacy should be emphasized [49]. 
Some of the factors influencing acceptability 
of HPV vaccination that women identified in this 
study were also reported by other studies, such 
as the need for information about the vaccine in 
relation to safety and side effects [50,51].
The impact of knowledge on behavior is 
complex and a variety of factors were seen 
to influence the young women’s decisions, 
such as their mothers’ influence, mass media 
campaigns, and family history of genital cancer. 
The strong impact of parental influence on 
young people has been recognized in other 
studies [52-56] and a reason against vaccination 
for parents concerns the risk that vaccine will 
increase dangerous sexual behaviours [57-59]. 
Factors influencing the decision to take the 
HPV vaccination should be further explored, but 
we recognized that the most likely cause for the 
low uptake of HPV vaccine is lack of financial 
resources: lowering the price of the vaccine (e.g. 
by reimbursement) might improve vaccination 
rates. Enforcing vaccination for children in 
universal programs and implementing school-
based vaccine mandates, rather than trying to 
improve vaccination rates among adolescents, 
is an effective way of spreading the method of 
primary prevention.
In summary, the decision of HPV 
vaccination was based on the message that 
the vaccine gave protection against cancer and 
on the fact that young women had confidence 
in the vaccination. The fact that the majority 
of respondents was aware of cervical cancer 
and had sufficient knowledge about Pap-test 
as a screening tool gives cause for moderate 
optimism. Disappointment is due to the fact 
that the main sources of information about 
HPV vaccination are represented by magazines, 
books and TV rather than healthcare workers. 
Therefore, educational campaigns should focus 
on gaps of knowledge regarding HPV, cervical 
cancer and vaccination -as identified in the 
present study- promoting sources that are 
mainly used by young women.
conclusIons 
It is important that health professionals 
provide comprehensible information about HPV 
vaccination while attaining informed consent. 
Our findings highlight the need to increase 
education regarding cervical cancer, HPV and 
counselling about HPV vaccination tailored to 
young women and their parents.
This pilot study demonstrates that the short 
version of the ad hoc questionnaire as a tool to 
examine knowledge, attitudes and behaviors 
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towards primary (anti-HPV vaccination) and 
secondary (pap-test screening) prevention of 
cervical cancer in young women in Italy has 
very good reliability properties and this needs 
to be taken into account in future studies.
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